These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4790575)

  • 41. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS; LeBlanc BM; Bodey GP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.
    Bran JL; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1972 Jan; 1(1):35-40. PubMed ID: 4596741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo evaluation of MDL 19,592, an oral cephalosporin.
    Erickson RC; Baumann RJ; Gibson CB; Hoffman PF
    J Antibiot (Tokyo); 1983 Oct; 36(10):1345-56. PubMed ID: 6605961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationships among a group of 7-(alpha-(N,N'-substituted-amidinothio)-acetamido) cephalosphoranic acids.
    Misiek M; Pursiano TA; Crast LB; Leitner F; Price KE
    Antimicrob Agents Chemother; 1972 Jan; 1(1):54-66. PubMed ID: 4670429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.
    Wick WE; Preston DA
    Antimicrob Agents Chemother; 1972 Mar; 1(3):221-34. PubMed ID: 5045468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.
    Actor P; Uri JV; Zajac I; Guarini JR; Phillips L; Pitkin DH; Berges DA; Dunn GL; Hoover JR; Weisbach JA
    Antimicrob Agents Chemother; 1978 May; 13(5):784-90. PubMed ID: 96734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.
    Chabbert YA; Lutz AJ
    Antimicrob Agents Chemother; 1978 Nov; 14(5):749-54. PubMed ID: 31836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.
    Neu HC
    Antimicrob Agents Chemother; 1974 Aug; 6(2):177-82. PubMed ID: 15828189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
    Russell AD; Tottle PC
    Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
    Hata K; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1894-901. PubMed ID: 1416879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing.
    Washington JA; Yu PK; Martin WJ
    Appl Microbiol; 1970 Feb; 19(2):259-63. PubMed ID: 4392357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.